Cargando…
Isatuximab in the Treatment of Multiple Myeloma: A Review and Comparison With Daratumumab
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasma cells. Although advances in treatment have markedly improved survival outcomes for patients with MM, this disease is still considered incurable owing to its high incidence of relapse and refractorin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340383/ https://www.ncbi.nlm.nih.gov/pubmed/35903924 http://dx.doi.org/10.1177/15330338221106563 |